India — Fishery/Seafood Products

← back to leaderboard

India received 99 FDA import refusals in Fishery/Seafood Products between 2023-Q4 and 2026-Q3. Volume peaked at 15 in 2025-Q2, with the trend falling sharply year-on-year. The most-cited issues are filthy, nitrofuran, and salmonella. No trade baseline is published for this commodity from India, so no per-$1B rate is shown here.

Of these, 96 were hazard refusals and 3 were paperwork refusals.

Exporting from India? Get an email when shipments from India are refused at the US border — before your buyers ask.

Quarterly rejections, last 12 quarters

11 2023-Q4 2023-Q4: 11 12 2024-Q1 2024-Q1: 12 8 2024-Q2 2024-Q2: 8 5 2024-Q3 2024-Q3: 5 6 2024-Q4 2024-Q4: 6 13 2025-Q1 2025-Q1: 13 15 2025-Q2 2025-Q2: 15 12 2025-Q3 2025-Q3: 12 3 2025-Q4 2025-Q4: 3 8 2026-Q1 2026-Q1: 8 3 2026-Q2 2026-Q2: 3 3 2026-Q3 2026-Q3: 3

By commodity, last 156 weeks

Commodity Rejections Per $1B US imports Most-cited hazard
Shrimp-Prawn 87 vetdrugres
Fish-Other 12 salmonella
Tuna 1 filthy
Squid-Octopus 0

Recent rejections